Please login to the form below
Coronavirus vaccine
This page shows the latest Coronavirus vaccine news and features for those working in and with pharma, biotech and healthcare.
Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
Pfizer and BioNTech have shared positive results from a phase 2/3 trial of two Omicron-adapted COVID-19 vaccine candidates. ... We will therefore remain vigilant and are prepared to rapidly adapt our Omicron-adapted vaccine candidates to emerging
Latest news
-
Sanofi and GSK report positive data for COVID-19 Beta vaccine
Sanofi and GSK have released positive data for their Beta vaccine to protect against COVID-19. ... The VAT08 vaccine trial assessed an adjuvant bivalent D614 and Beta (B.1.351) vaccine.
-
EU governments pressure manufacturers to renegotiate contracts for COVID-19 vaccines
EU officials have warned that millions of vaccine doses could be wasted due to over-supply. ... Pressure on COVID-19 vaccine manufacturers is being mounted as European Union (EU) governments are in a push to renegotiate contracts, with a caution issued
-
Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
A third dose of the vaccine has been trialled in children aged from six months to under five years old. ... of their COVID-19 vaccine for children aged from six months to under five years old.
-
Sanofi begins construction on the first of two Evolutive Vaccine Facilities in Singapore
stepping stone to ‘pave the way for future vaccine innovation across the world’. ... Comparably, current manufacturing sites only allow for the production of a single vaccine.
-
Gavi, MedAccess and the Open Society Foundations partner to support COVAX
The Global Alliance on Vaccines and Immunisation (GAVI), MedAccess and the Open Society Foundations have come together to help countries access additional COVID-19 vaccine doses, by creating a risk-sharing ... Innovative financing solutions are crucial
More from news
Approximately 54 fully matching, plus 72 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Coronavirus will be a blip on the horizon in comparison. The risk is trivial.”. ... Notably, Russia’s Sputnik V vaccine, developed by Moscow’s Gamaleya research centre, and announced by President Vladimir Putin in August as being the world’s
-
Multilingual remote conferencing and interpreting platforms in the era of COVID-19
The conference listings for 2020 were well established, but as the coronavirus became a more severe threat, the months of upfront planning were put on hold. ... In April this year there were 650 groups around the world carrying out 460 different
-
Developing a COVID-19 vaccine
GlaxoSmithKline has also partnered with Chinese biotech company Clover Biopharmaceuticals on a protein-based coronavirus vaccine candidate, named COVID-19 S-Trimer. ... Translate has already begun to produce multiple mRNA constructs and will use its
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
to use mRNA vaccine technology and among the first to use viral vectors,. ... The Independent. https://www.independent.co.uk/news/world/americas/coronavirus-vaccine-phase-3-covid-fda-cure-a9704111.html. Published 2020. Accessed May 26, 2021. 5. About the
-
Vaccine hesitancy eBook
Download the PDF to explore:. Original research findings on the deeper drivers behind vaccine hesitancy and the benefits of taking a human-centred approach for increasing vaccine uptake. ... The motivations behind the Arm in Arm campaign, a global
-
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
But perhaps the biggest challenge is getting people to have the vaccine at all. ... dose of a coronavirus vaccine (as of 14/02/21), what the real-world experience is telling us about side effects.
-
Travel in the time of COVID
1. The vaccine roll out in the EU markets is proving to have a lot of grit in the system, from approvals and licensing, to pricing challenges, to logistics. ... The vaccine developers are staying on top of the mutant strains and getting just enough
-
Should diversity in clinical trials be mandatory?
In October 2020, of the 270, 000 people already recruited to coronavirus vaccine trials, only 7% were ethnic minorities.
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Biogen and Happify Health team up to create digital platform for MS patients
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Moderna to launch Innovation and Technology Center in the UK
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Gilead Sciences supports Kigali Declaration for neglected tropical diseases
- As the NHS turns 74, it launches its ‘biggest NHS Big Tea ever’ to raise funds
- FDA issues innovative proposal to increase nonprescription drug access
- European Commission approves potential new treatment for Pompe disease
- Connect to the conversation around mental health: A spotlight on physician burnout
- How understanding the rare disease patient’s lived experience creates better health communications
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Roche shares new positive Ocrevus data for MS patients
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Annovis Bio’s lead therapeutic shows ‘significant improvements’ in Alzheimer’s, Parkinson’s
- Phase 3 trial initiated to evaluate AZ's Saphnelo in lupus nephritis
- New virtual health and care report from WHO and Novartis calls for ‘critical action’
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- Virtual MSL/Sales training programs and events
- Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
- Omnichannel strategies to revolutionize the healthcare professional experience
- Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...
